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2.5. Data analysis 
The data analysis has been carried out using binding equations ac- 
cording to a linkage scheme [IQ, which has been adapted to the differ- 
ent experimental conditions. Therefore, in the case of BPTI and ben- 
zamidine binding (columns a and c in Table 1) the following general 
equation has been employed 
r= ,F, K,xl(l + K,x). l/n 
where ? is the fraction of free binding sites in the enzyme, x is the 
concentration of free inhibitor and K, is the equilibrium association 
constant to the i site. The digit n corresponds to the number of types 
of binding sites (n = 4 was used for BPTI binding and n = 1 for ben- 
zamidine binding). In addition, the possibility of a cooperative interac- 
tion has been taken into account for the binding of BPTI to bovine 
tryptase (see below), and in this case the following modified version of 
Eq. (1) has been employed (see column b in Table 1): 
r= K,x + K,x + 2K,K,x’ 2 + ‘g K,l(1 + K,x) 1 In 
2(1 f K,x + Kzx + K,K2x2) n (la) ,=3 
where n = 4 and the other symbols have the same meaning as for Eq. 
(I). 
In the case of benzamidine binding to bovine tryptase wherefore the 
two higher affinity sites had been already bound to BPTI (see below and 
column d in Table 1) the following equation has been employed: 
r= K,x + K4x + 2K,K,x2 
2(1 f K+ + K4x + KiK4x2) (lb) 
where the symbols have the same meaning as for Eq. (1) and Kj and 
K4 have been used since indeed the binding constants refer to the sites 
3 and 4 of the BPTI binding process. Analysis of the data was per- 
formed using a Marquardt algorithm. 
3. Results and discussion 
3.1. Binding of BPTI to bovine tryptase 
Steady-state kinetic data on few synthetic substrates for bo- 
vine tryptase did not show any significant deviation from a 
Michaelis-Menten mechanism [7] and the corresponding data 
at 30°C for one of these substrates (i.e. Boc-Phe-Ser-Arg- 
MCA) are reported as a note in Table 1. However, it must be 
pointed out that synthetic substrates, which are usually em- 
ployed for this type of measurements, may not be very suitable 
for detecting fine site-site interactions. In fact, their action is 
mostly influenced by the stereochemistry of the primary speci- 
Table 1 
Intrinsic association constants for BPTI and benzamidine binding to 
bovine tryptase” 
Intrinsic Inhibitor 
association 
constant BPTI Benzamidine 
(M-l)* 
K, 
K2 
K3 
k 
a b C d 
1.21 x lo* 3.87 x 10’ 5.5 x lo4 
1.21 x 108 3.53 x 108 
2.70 x 10’ 2.29 x lo6 1.53 x lo4 
2.22 x lo4 2.28 x lo4 1.43 x lo6 
Residual activity was measured in all experiments at 30°C in 0.1 M 
Tris-HCl, pH 8.0. 
“The steady state parameters for the interaction of Boc-Phe-Ser-Arg- 
MCA with bovine tryptase at 3O”C, pH 8.0 are as follows: 
K,,, = 9.4x lo-’ M, kc,, = 19.8 s-l, k-,/K, = 2.11 x lo5 M-‘.s-‘. 
*The intrinsic association constants were obtained by non linear least- 
squares curve fitting using Eq. (1) (column a, n = 4, and column c, 
n = I), equation la (column b, n = 4) and equation lb (column d). 
Other details are reported in section 2.5. 
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Fig. 1. BPTI binding to bovine tryptase. Binding was measured (open 
symbols) as described in section 2. The curves are non linear least- 
squares fits of equation 1 (- --) and of equation la (-) to the experimen- 
tal data (n = 4). The dotted line represents the fitting obtained when 
only two types of binding sites were considered (Eq. (l), IZ = 2). Tryp- 
tase concentration was 5 nM active sites. Experiments were performed 
at 3O”C, in 0.1 M Tris-HCl, pH 8.0. For details see section 2.5. 
ficity site and by the efficiency of the charge-relay system in the 
catalytic triad, which, although crucially important for the en- 
zyme action, represents only a limited portion of the protein 
surface which contributes to the in vivo interaction with macro- 
molecular substrates or inhibitors. Therefore, the study of the 
functional interaction between subunits (and sites) of bovine 
tryptase has been undertaken investigating in a combined fash- 
ion the binding of small synthetic and of large macromolecular 
inhibitors, such as benzamidine and BPTI, the endogenous 
inhibitor co-existing with bovine tryptase in the mast cells gran- 
ules. Our aim was to possibly uncover conformational changes 
of larger portions of the enzyme, even not immediately neigh- 
bouring the active catalytic site. In fact, the wider interaction 
surface of macromolecular inhibitors seems to be more suscep- 
tible of detecting, and of being influenced by, long range ligand- 
linked structural transitions of the subunits. 
Fig. 1 displays the equilibrium binding of BPTI to tryptase 
at pH 8.0, 3O”C, in 0.1 M Tris-HCl, a process which clearly 
appears multiphasic. Such a behaviour can be referred to either 
(i) the presence of multiple types of inhibitor binding sites with 
different intrinsic affinities; or (ii) the occurrence of a negative 
cooperative interaction between sites, such that, after few bind- 
ing sites are occupied by the inhibitor, a conformational change 
takes place, which lowers the affinity of the ligand for the 
remaining binding sites. Indeed, a discrimination between case 
(i) and case (ii) is not easy, even though we can definitely rule 
out any marked intrinsic functional heterogeneity for the pri- 
mary specificity site as well as for the catalytic site of tryptase. 
As a matter of fact, binding of a small synthetic inhibitor, such 
as benzamidine, which only interacts with Asp’** of tryptase 
through its amino group [ 131 and our own unpublished results), 
displays a simple binding behaviour (see open symbols in Fig. 
2 and Table 1, column c), and the same seems to be true for 
the binding of a synthetic substrate (see note in Table 1). There- 
fore, the eventual applicability of case (i) should be referred 
only to variations among the secondary specificity sites con- 
cerning the widespread network of interactions present only 
when a large surface of the enzyme binds a macromolecular 
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Fig. 2. Benzamidine binding to bovine tryptase. Binding was measured 
as described in section 2, in the absence (open symbols) and in the 
presence (filled symbols) of 100 nM BPTI (a concentration inhibiting 
half of the enzyme activity). The curves are non-linear least-squares fits 
of Eq. (I), n = 1 (-) and of Eq. (lb) (---) to open and to filled symbols, 
respectively. The dotted line represents the curve fitting of Eq. (1) 
(n = 1) to the filled symbols. Tryptase concentration was 5 nM active 
sites. Experiments were performed at 3O”C, in 0.1 M Tris-HCl, pH 8.0. 
For details see section 2.5. 
inhibitor. Furthermore, a mechanism involving the degradation 
of inhibitor by tryptase during the process of inhibition can be 
ruled out. In fact, at various inhibitor/enzyme molar ratios, no 
cleavage of BPTI occurred, as we could evaluate from the 
HPLC profile of the incubation mixtures. Under the conditions 
used for the elution of the inhibitor, only one peak correspond- 
ing to unchanged BPTI was detected. 
In view of these considerations, case (ii) may also include the 
possibility that the binding affinity decrease, observed only in 
the case of a large macromolecular inhibitor, might reflect some 
steric hindrance. Therefore, in such a case the close proximity 
of some of the binding sites and the occupancy of one of them 
impair (or weaken) the interaction of the neighbouring site with 
another large inhibitor molecule because of the partial surface 
overlapping of the secondary specificity site. It is interesting to 
recall that very recently Sommerhoff et al. [ 191 have shown that 
LDTI, a Kazal-type inhibitor (46 amino acid residues) isolated 
from the leech Hirudo medicinalis, inhibits only 50% of the 
proteolytic activity of human tryptase, up to a 40 nM inhibitor 
concentration. However, in the light of our data (Fig. l), the 
leech inhibitor concentration used could be not sufficient to 
detect lower affinity sites in human tryptase. 
A closer look of BPTI binding to bovine tryptase indicates 
that the complete description of the functional behaviour re- 
quires the presence of at least four binding sites, two of which 
show high affinity properties, whereas the other two display 
drastically different and much lower affinity constants. Thus, 
the overall curve cannot be satisfactorily fitted with only two 
types of binding sites (using Eq. (l), see dotted curve in Fig. 1). 
As a consequence, the analysis of BPTI binding has been car- 
ried out employing Eq. (1) and (la), either (a) assuming the 
same value for the equilibrium constant of the two high affinity 
sites, or (b) leaving them free to vary (Table 1, column a and 
b). These two cases are reported in Fig. 1 (dashed line for case 
(a) and continuous line for case (b)), and it turns out that a 
somewhat better fitting can be obtained when some cooperativ- 
ity between the two high affinity binding sites is introduced. An 
-9-fold enhancement is found for the second binding constant, 
suggesting a possible interaction energy between the two bind- 
ing sites of -5.5 kJlmo1. However, it must be pointed out that 
the slight scattering of the data puts a fairly large error on this 
estimate, whereas their quality is good enough to confirm the 
occurrence of a four-site functional unit. 
3.2. Binding of benzamidine to bovine tryptase in the presence of 
BPTI 
The presence of binding sites with drastically different affin- 
ity constants in bovine tryptase offers the opportunity to inves- 
tigate the functional properties of intermediate situations, when 
only a fraction of binding sites is occupied by the macromolecu- 
lar inhibitor, such as to possibly detect the existence of confor- 
mational arrangements of the enzyme differing from the totally 
free and the fully saturated molecule. In this respect, we have 
carried out an investigation on the properties of tryptase in the 
presence of a concentration of BPTI, which was enough to 
occupy only the two high affinity binding sites. Strikingly, ben- 
zamidine binding to the two remaining unoccupied binding 
sites shows distinctly different interaction properties (see filled 
symbols in Fig. 2). As a matter of fact, an overall significant 
enhancement of the affinity constant for benzamidine can be 
immediately detected. Furthermore, the analysis of this binding 
behaviour unequivocally shows the occurrence of a very 
marked positive cooperativity between the two binding sites 
with an - lOO-fold enhancement of the affinity constant for the 
binding of the second molecule of benzamidine, underlying an 
interaction energy between the two sites of - 11.4 kJ/mol (Table 
1, column d). 
3.3. Conclusions 
A complete quantitative description of the whole behaviour 
described is not easy and likely impossible at this stage. How- 
ever, we can try to give some hint of possible interaction net- 
works operating in bovine tryptase, and to try some extrapola- 
tions to its in vivo role. 
First of all, a feature which undoubtedly emerges from this 
functional study is the existence of a complex interaction mech- 
anism within a functional unit which can be identified as 
formed by (at least) four binding sites. Within this framework, 
we can envisage the possible existence of a weak positive coop- 
erativity between two sites which is transmitted only through 
a ligand-linked conformational change involving the secondary 
specificity site, since no evidence for such a phenomenon can 
be observed if the ligand binding occurs only at the primary 
specificity site (such as in the case of benzamidine binding). At 
this point, the occupancy of two sites creates a new structural 
situation, wherefore the binding of a third macromolecular 
inhibitor is strongly impaired by a decrease of - 12.6 kJ/mol of 
free energy. However, this effect is likely due to a steric hin- 
drance of the secondary specificity site, since it can be observed 
only for a large inhibitor macromolecule, whereas the affinity 
of the primary specificity site for a small synthetic inhibitor, 
such as benzamidine, (even in the presence of two sites occupied 
by the macromolecular inhibitor) is only weakly affected. The 
existence of a new interaction network at intermediate ligand 
saturation degrees is further demonstrated by the evidence that 
in the presence of half of the sites occupied by the macromo- 
lecular inhibitor there is a strong positive interaction between 
84 L. Fiorucci et al. I FEBS Lerters 363 (1995) 81-84 
the two primary specificity sites, which is not present in the 
absence of BPTI. 
Altogether, it appears that the ligand binding behaviour of 
bovine tryptase displays a complex interplay between positive 
and negative interaction effects, which becomes evident only in 
the presence of extended surface interaction, suggesting a pos- 
sible relevant role in the in vivo interaction with macromolecu- 
lar substrates. Therefore, a detailed quantitative description of 
this peculiar behaviour, even though it is clearly outside the 
purpose of this initial study, may contribute to a deeper com- 
prehension of physiological role of mast cell tryptase. 
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